News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Immune Oncology
Breast Oncology
Gastrointestinal Oncology
Lung Oncology
Hematology
Radiotherapy
Cancer Types
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025
Yvonne Award 2025

Jun / 2026

June 2026
M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

« May

OncoDaily IO OncoDaily GI Hemostasis Today Fertility News

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter

25 Posts Not To Miss From ASCO 2026 Day 4

25 Posts Not To Miss From ASCO 2026 Day 4

Yvonne Awards 2026 Honored Leaders Shaping the Future of Oncology

Yvonne Awards 2026 Honored Leaders Shaping the Future of Oncology

AEGEAN Trial: Durvalumab Reshapes the Tumor Microenvironment in Resectable NSCLC

AEGEAN Trial: Durvalumab Reshapes the Tumor Microenvironment in Resectable NSCLC

HARMONi-6 Trial at ASCO Plenary 2026: Ivonescimab Plus Chemotherapy Improves Overall Survival in Advanced Squamous Non-Small Cell Lung Cancer

HARMONi-6 Trial at ASCO Plenary 2026: Ivonescimab Plus Chemotherapy Improves Overall Survival in Advanced Squamous Non-Small Cell Lung Cancer

Vivek Subbiah: Global Access to Tumor-Agnostic Therapies

Vivek Subbiah: Global Access to Tumor-Agnostic Therapies

mRCAT-III at ASCO 2026: Node-Sparing RT Plus CAPOX and Tislelizumab in MSS Locally Advanced Rectal Cancer

mRCAT-III at ASCO 2026: Node-Sparing RT Plus CAPOX and Tislelizumab in MSS Locally Advanced Rectal Cancer

A Year to Remember at ASCO 26 - GI Cancers Alliance

A Year to Remember at ASCO 26 - GI Cancers Alliance

Roberta Elisa Rossi

Jun 30, 2024 12:05 pm

Insight

The situation around GEP-MiNENs in Italy

The situation around GEP-MiNENs in Italy

Jun 8, 2024 11:09 pm

Blog Posts

Francesca Spada: VI edition of the IEO NET functioning course

Francesca Spada: VI edition of the IEO NET functioning course

Headlines

Nazik Hammad: A Landmark Moment for LMIC Representation at ASCO

New Trial Tests Trabectedin With Radiotherapy in Retroperitoneal L-Sarcoma

CodeBreaK 300 at ASCO 2026: ctDNA Clearance Evaluated as an Early Response Biomarker in KRAS G12C-Mutated mCRC

International Partnerships Aim to Mitigate Cancer Care Disruptions in Ukraine - AACR

Is RAS No Longer Undruggable? Discussions on RASolute Trial That Earned Standing Ovation at ASCO26

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer Breast Cancer fight against cancer ASCO Global fight against cancer cancer care Lung cancer Cancer research Headlines ESMO immunotherapy NSCLC MD Anderson Cancer Center cancer treatment cancer awareness colorectal cancer Research clinical trials Childhood Cancer ASCO24 AACR FDA prostate cancer UICC Dana-Farber Cancer Institute American Cancer Society chemotherapy SIOP European Cancer Organisation Robert Orlowski Pancreatic Cancer American Society of Clinical Oncology Myeloma Paper of the Day NCI Paolo Tarantino Myeloma Vivek Subbiah AI radiation oncology National Cancer Institute cervical cancer WHO IASLC healthcare Memorial Sloan Kettering Cancer Center multiple myeloma bladder cancer Zainab Shinkafi-Bagudu

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}